Consistent with the dispensable role of CD8+ T cell in this process, disrupting cDC1-dependent cross-priming of CD8+ T cells using Batf3-deficient hosts did not affect the tumor suppressive effect of NEC immunization (Fig. 4d). This evidence concerns the gene BATF3 and neoplasm.